Epineuron Technologies Closes Financing for its Breakthrough Nerve Regeneration Device

Ontario Industry Updates
Written By Guest User
small logo2.png

Epineuron Technologies, Inc., a bioelectronic medicine company, announced the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.

Guest User
Previous

MyndTec Partners with Maness Veteran Medical to Distribute MyndMove™ to US Veterans and Active Military
Next

Spiderwort closes $2.5M USD Series Seed Financing